Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Cellectis (CLLS)

  • Business News
  • Nov. 27, 2025, 12:15 UTC
  • 24
  • 1 comments

Cellectis organise un webinaire dédié aux actionnaires français le jeudi 4 décembre 2025

Market reaction Comment Full text

Nutex Health Inc (NUTX)

  • Business News
  • Nov. 27, 2025, 11:15 UTC
  • 15
  • 1 comments

GE HealthCare announces CE Mark for new digital 4D SPECT/CT system, StarGuide GX

Market reaction Comment Full text

Mesoblast Limited (MESO)

  • Business News
  • Nov. 27, 2025, 07:32 UTC
  • 15
  • 1 comments

Ceasing to be a substantial holder

Market reaction Comment Full text

HUTCHMED DRC (HCM)

  • Business News
  • Nov. 27, 2025, 00:14 UTC
  • 16
  • 1 comments

[Press Release] HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting

Market reaction Comment Full text

HUTCHMED DRC (HCM)

  • Business News
  • Nov. 27, 2025, 00:00 UTC
  • 20
  • 1 comments

HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting

Market reaction Comment Full text

United Therapeutics Corporation (UTHR)

  • Business News
  • Nov. 26, 2025, 21:42 UTC
  • 9
  • 1 comments

UTHR: Notification

Market reaction Comment Full text

United Therapeutics Corporation (UTHR)

  • Business News
  • Nov. 26, 2025, 21:42 UTC
  • 12
  • 1 comments

UTHR: Notification

Market reaction Comment Full text

United Therapeutics Corporation (UTHR)

  • Business News
  • Nov. 26, 2025, 21:42 UTC
  • 11
  • 1 comments

UTHR: Notification

Market reaction Comment Full text

Beyond Air (XAIR)

  • Business News
  • Nov. 26, 2025, 21:30 UTC
  • 14
  • 1 comments

Beyond Air® Announces Transition of Chief Financial Officer

Market reaction Comment Full text

Zoetis Inc. (ZTS)

  • Business News
  • Nov. 26, 2025, 21:15 UTC
  • 7
  • 1 comments

Zoetis - Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs

Market reaction Comment Full text
  • Previous
  • 500
  • 501
  • 502
  • 503
  • 504
  • Next

Search

News categories

  • Technical Exchange News(10945)
  • Event(2382)
  • SEC News(191826)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125282)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin